Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 ...
LEXINGTON, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat
Jasbirs Seehra Justin Frantz Company Quarterly Report On Form Hansoh Shanghai Healthtech Co Ltd Keros Therapeutics Inc Exchange Commission
Source: eagletribune.com